Portfolio comparison
Johns Hopkins University vs Immatics Biotechnologies
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Johns Hopkins University
Patents indexed
2
Year range
2002 – 2018
Most recent
2018
biotechpharmaceutical
Top Patents2 enriched
US 6458360· 2002
How to Create Lab-Made Proteins That Stop Immune System Overreaction
US RE46907· 2018
Using Plant-Derived Chemicals and Metabolic Drugs to Fight Cancer
Activity by Decade
2000s1
2010s1
Company B
Immatics Biotechnologies
Patents indexed
7
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapyoncologygene_editing
Top Patents7 enriched
US 11407807· 2022
Using Specific Immune Cells to Fight Cancers Like Lung and Breast Cancer
US 10377797· 2019
Training Immune Cells to Fight Cancer Using Specific Markers
US 10314897· 2019
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
Activity by Decade
2010s3
2020s4
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.